En Es
Categories

QUOTIENT DIAGNOSTICS

Quotient is a commercial-stage diagnostics company that develops and manufactures products for use in transfusion diagnostics. It offers a next-generation automation platform for both blood grouping and donor disease screening, products for blood grouping, and whole blood controls for quality assurance testing of third-part ...
Products Covid-19Summary
Close

Covid-19 QUOTIENT DIAGNOSTICS

Clinical Laboratory

Blood Testing Platform
MosaiQ

The MosaiQ is the world’s first fully-automated testing solution that will allow for rapid, extensive antigen typing/antibody identification of donor and patient blood utilizing a single Microarray (or consumable). It enables workflow efficiencies through walk-away-capable processing of approximately 1,000 samples in a single 8-hour shift. The MosaiQ COVID-19 Antibody Microarray combines with the multiplexing, high-throughput MosaiQ instrument to quickly and accurately evaluate samples in central laboratories.
More details

COVID-19 IgM/IgG Antibody Test
MosaiQ COVID-19 Antibody Microarray

The MosaiQ COVID-19 Antibody Microarray tests for both IgM and IgG antibodies to SARS-CoV-2, the virus that causes COVID-19, offering one of the earliest antibody detection tests available. Independent and internal studies have confirmed best-in-class performance with 100% sensitivity and 99.8% specificity. It can detect seroconversion as early as 24 hours post PCR and detects antibodies as early as 7 days post PCR. The innovative technology that allowed Quotient to create the MosaiQ COVID-19 Antibody Microarray is powered by the proprietary MosaiQ Reaction that delivers fast, accurate results every 24 seconds on the MosaiQ system – a multiplexing, multimodal solution for central laboratories. The best-in-class MosaiQ COVID-19 Antibody Microarray is CE marked, has received the U.S. FDA Emergency Use Authorization (EUA).
More details
Close

About QUOTIENT DIAGNOSTICS

Quotient is a commercial-stage diagnostics company that develops and manufactures products for use in transfusion diagnostics. It offers a next-generation automation platform for both blood grouping and donor disease screening, products for blood grouping, and whole blood controls for quality assurance testing of third-party blood grouping instruments.
FaceBook Twitter Google+ Linked in
COVID-19 IgM/IgG Antibody Test

COVID-19 IgM/IgG Antibody Test

Model: MosaiQ COVID-19 Antibody Microarray
Request Information

Description:

The MosaiQ COVID-19 Antibody Microarray tests for both IgM and IgG antibodies to SARS-CoV-2, the virus that causes COVID-19, offering one of the earliest antibody detection tests available. Independent and internal studies have confirmed best-in-class performance with 100% sensitivity and 99.
Read More

Full Description

Description

The MosaiQ COVID-19 Antibody Microarray tests for both IgM and IgG antibodies to SARS-CoV-2, the virus that causes COVID-19, offering one of the earliest antibody detection tests available. Independent and internal studies have confirmed best-in-class performance with 100% sensitivity and 99.8% specificity. It can detect seroconversion as early as 24 hours post PCR and detects antibodies as early as 7 days post PCR. The innovative technology that allowed Quotient to create the MosaiQ COVID-19 Antibody Microarray is powered by the proprietary MosaiQ Reaction that delivers fast, accurate results every 24 seconds on the MosaiQ system – a multiplexing, multimodal solution for central laboratories. The best-in-class MosaiQ COVID-19 Antibody Microarray is CE marked, has received the U.S. FDA Emergency Use Authorization (EUA). Request Information

Send A Message To This Supplier

* Required Information
* Email
To
QUOTIENT DIAGNOSTICS (COVID-19 IgM/IgG Antibody Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions